The economic burden of uncontrolled asthma across Europe and the Asia-Pacific region: Can we afford to not control asthma?

European Respiratory Review

Volumn 15, Issue 98, 2006, Pages 1-3

  Bateman, E D ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Dept of Medicine   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASIA; ASTHMA; CAREGIVER; COMPARATIVE STUDY; DISEASE CONTROL; DRUG COST; DYSPNEA; ECONOMICS; EDITORIAL; EMERGENCY WARD; EUROPE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH SERVICE; HOSPITALIZATION; HUMAN; MORBIDITY; PRACTICE GUIDELINE; QUESTIONNAIRE;

EID: 33947422475     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.06.00009800     Document Type: Editorial

References (22)

1. World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva, World Health Organisation, 2002; 68-76.
2. Rabe K, Vermeire P, Soriano J, Maier W. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807.
3. Lai CKW, de Guia TS, Kim Y-Y, et al. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 2003; 111: 263-268.
4. Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40-47.
5. Masoli M, Fabian D, Holt S, Beasley R. Global Burden of Asthma. (Work commissioned by Global Initiative for Asthma/GINA), 2004. http://www.ginasthma. com/ReportItem.asp?l1=2&l2=2&intId=94. Date last accessed: April 5, 2006.
6. Vervloet D, Williams AE, Lloyd A, Clark TJH. Costs of managing asthma as defined by a derived Asthma Control Test™ score in seven European countries. Eur Respir Rev 2006; 98: 17-23.
7. Lai CKW, Kuo S-H, de Guia T, Lloyd A, Williams AE, Spencer MD. Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test™ score in eight Asia-Pacific areas. Eur Respir Rev 2006; 98: 24-29.
8. Williams AE, Lloyd AC, Watson L, Rabe KF. Cost of scheduled and unscheduled asthma management in seven European Union countries. Eur Respir Rev 2006; 98: 4-9.
9. Lai CKW, Kim Y-Y, Kuo S-H, Spencer M, Williams AE on behalf of the Asthma Insights and Reality in Asia Pacific Steering Committee. Cost of asthma in the Asia-Pacific region. Eur Respir Rev 2006; 98: 10-16.
10. Global Strategy for Asthma Management and Prevention, Bethesda, MD, NIH publication No. 02-3659. Issued January, 1995. Updated 2005 from the 2004 document. Also available on www.ginasthma.org.
11. Roche N, Morel H, Martel P, Godard P. Clinical practice guidelines: medical follow-up of patients with asthma - adults and adolescents. Resp Med 2005; 99: 793-815.
12. Li JT, Oppenheimer J, Bernstein IL, Nicklas RA, for the Joint Task Force Reviewer. Attaining optimal asthmacontrol: a practice parameter. J Allergy Clin Immunol 2005; 116: S3-S22.
13. Bateman ED, Homer A, Boushey JB, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med 2004; 170: 836-844.
14. British guidelines on the management of asthma. Pharmacological management. Thorax 2003; 58: Si17-Si28.
15. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
16. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907.
17. Juniper EF, Bousquet J, Abetz L, Bateman ED, the GOAL Committee. Identifying "well-controlled" and not well-controlled" asthma using the Asthma Control Questionnaire. Resp Med 2006; 100: 616-621.
18. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999; 160: 1647-1652.
19. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy 1996; 26: Suppl. 1, 1-24.
20. Sullivan SD, Buxton M, Andersson LF, et al. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2003; 122: 1229-1236.
21. Lyseng-Williamson KA, Plosker GL. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma. Pharmacoeconomics 2003; 21: 951-989.
22. Sullivan SD, Weiss KB, Lynn H, et al. The cost-effectiveness of an inner-city asthma intervention in children. J Allergy Clin Immunol 2002; 110: 576-581.